CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar mwtbgthwallst (< 20) Submitted: 2/3/2011 5:09:14 PM : Outperform Start Price: $5.21 CRY Score: -12.61

Because I said so.

Featured Broker Partners


Advertisement